More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (-7.5% Growth)
- Ratings (3.0 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/21/17 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 232.12M
Short-term investments
Accounts receivable, net 239.59M
Inventory, net 167.55M
Deferred product manufacturing costs
Deferred income taxes
Prepaid expenses and other current assets 61.32M
Total current assets 700.59M
Property, plant and equipment, net 227.59M
Deferred product manufacturing costs
Deferred income taxes, net 36.67M
Other assets 55.21M
Goodwill 208.38M
Total assets 2.12B
Current liabilities:
Accounts payable 61.89M
Accrued expenses 235.18M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 19.76M
Deferred revenue
Total current liabilities 334.53M
Deferred revenue
Other liabilities 68.89M
Total liabilities 1.22B
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 742K
Additional paid-in capital 531.3M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -3.8M
Retained earnings 377.78M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 903.86M
Total liabilities and stockholders' equity 2.12B